Redeye provides an initial take on BONESUPPORT’s Q1 results and we note another estimate beat on sales, resulting in a break-even operating result. Furthermore, CERAMENT G in the US came in significantly higher than our (conservative) numbers. We anticipate a positive share price reaction of c10%. We will return shortly with a more in-depth take on the report following the conference call.
LÄS MER
